Medtronic is recalling remote controllers used with its MiniMed 508 insulin pump and MiniMed Paradigm family of insulin pumps due to dangerous security flaws. The Food and Drug Administration on ...

Medical device maker Medtronic has expanded its recall of remote controllers for its MiniMed 508 and MiniMed Paradigm insulin pumps. The reason? The devices are a potential cybersecurity risk.

Medtronic expanded a recall of remote controllers used with MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps due to potential cybersecurity risks, according to an FDA press ...

Medtronic has expanded a 2018 recall of insulin pump remote controls to include all remote controls used with the MiniMed 508 insulin pump and the MiniMed Paradigm family of insulin pumps.

Medtronic's Adapt trial put the algorithm-equipped MiniMed 780G insulin pump to the test against one standard of care for Type 1 diabetes.

The US Food and Drug Administration issued a warning on Thursday about possible risk of hacking for some diabetes patients' insulin pumps. Certain insulin pumps from Medtronic MiniMed have been ...

This Class I recall applies to all MiniMed remote controllers-- including models MMT-500 and MMT-503 -- that are used with a Medtronic MiniMed 508 insulin pump or the MiniMed Paradigm family of pumps.

Medtronic is expanding a recall of two of its MiniMed 600 series insulin pumps after reports found several had broken retainer rings cracked, resulting in insulin doses that were too high or too low.

Two years after submitting the MiniMed 780G system for FDA approval, Medtronic finally secured the agency’s signoff to begin selling it in the U.S.

The MiniMed TM 670G gained approval in 2016 for people ages 14 and older and in 2018 for children ages 7 to 13 years, he said. Since then, use of the MiniMed TM 670G has grown to more than 180,000 ...

Medtronic Inc has asked software security experts to investigate the safety of its insulin pumps, as a new claim surfaced that at least one of its devices could be hacked to dose diabetes patients ...

Medtronic plc, of Dublin, has gained CE-marking approval for its Minimed 780g system, a next-generation closed-loop insulin pump for people with type 1 diabetes between the ages of 7 and 80 years old.